Travere Therapeutics Inc

TVTXNASDAQ · US

Holders

REDUCEDT+7
Lyons Gary A
Travere Therapeutics Inc · NASDAQ
−900 sh · $57.5K
Filed 19 Aug 2026SEC Form 4view source
ACQUIREDT+7
Lyons Gary A
Travere Therapeutics Inc · NASDAQ
+5,000 sh · $87.2K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDT+7
Lyons Gary A
Travere Therapeutics Inc · NASDAQ
−1,900 sh · $118.8K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDT+7
Lyons Gary A
Travere Therapeutics Inc · NASDAQ
−2,600 sh · $165.1K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDT+7
Lyons Gary A
Travere Therapeutics Inc · NASDAQ
−500 sh · $32.1K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDT+7
Lyons Gary A
Travere Therapeutics Inc · NASDAQ
−4,100 sh · $259.4K
Filed 19 Aug 2026SEC Form 4view source
ACQUIREDT+7
Lyons Gary A
Travere Therapeutics Inc · NASDAQ
+5,000 sh · $87.2K
Filed 19 Aug 2026SEC Form 4view source
DISCLOSEDQuarterly
Renaissance Technologies
Travere Therapeutics Inc · NASDAQ
1,833,079 sh · $104.1M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDQuarterly
Polen Capital Management
Travere Therapeutics Inc · NASDAQ
34,315 sh · $1.9M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDQuarterly
Renaissance Technologies
Travere Therapeutics Inc · NASDAQ
1,966,779 sh · $58.4M
Filed 31 Mar 2026SEC 13Fview source